Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...

Clinical genomics laboratories are no longer limited to research settings; they are increasingly integrated into routine ...

Please provide your email address to receive an email when new articles are posted on . A functional precision medicine approach produced significant objective response, PFS in children with cancer.

VANCOUVER, British Columbia-- (BUSINESS WIRE)--Contextual Genomics, developers of genomics-based cancer tests, and the Personalized Medicine Initiative (PMI), an organization bringing molecular-based ...

OXFORD, England, April 11-- Massachusetts Mutual Life Insurance, a life insurance company, issued the following news release on April 10, 2024: OXFORD, England & SPRINGFIELD, Mass.-- Genomics plc ...

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the only U.S. Food and Drug Administration (FDA) cleared test for celiac genetics, today announced the ...

(RTTNews) - Targeted Genomics LLC, creator of GlutenID—the first and only FDA-cleared direct-to-consumer genetic test for celiac disease—has entered a commercial partnership with OraSure Technologies, ...

VANCOUVER, British Columbia & FOUNTAIN VALLEY, Calif. — Contextual Genomics, a leading cancer genomics company, and Lab Genomics, a personalized medicine company providing state of the art molecular ...

$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products Fast-growing SneakPeek test has helped 750,000 parents learn baby’s gender from home – earliest ...

On March 12th, the Saudi National Unified Procurement Company (NUPCO) officially announced the bidding results for the three-year centralized procurement project for outsourced testing services for ...